# CLCA1

## Overview
The CLCA1 gene encodes the protein chloride channel accessory 1, which is a member of the calcium-activated chloride channel regulator family. This protein plays a pivotal role in modulating chloride ion transport across epithelial cell membranes, primarily by interacting with and stabilizing the TMEM16A/Anoctamin1 channel, a calcium-activated chloride channel. Unlike transmembrane proteins, CLCA1 is secreted in a globular form and does not form channels itself but acts as a regulator. It is predominantly expressed in the gastrointestinal tract, where it contributes to mucus dynamics and epithelial fluid secretion. CLCA1 is also involved in respiratory function, where its dysregulation is linked to diseases such as asthma and chronic obstructive pulmonary disease (COPD) due to its role in mucus production. Additionally, CLCA1 has been identified as a tumor suppressor in colorectal cancer, where its expression is often reduced, correlating with increased tumor aggressiveness (Liu2019Calciumactivated; Li2017CLCA1; SalaRabanal2015Secreted).

## Structure
The CLCA1 protein is a member of the calcium-activated chloride channel regulator family and is involved in modulating chloride ion transport. It is encoded by a gene located on chromosome 1 (p22-31) and consists of 31,902 base pairs, 15 exons, and 14 introns (Liu2019Calciumactivated). The protein is secreted as a globular form without transmembrane domains, indicating it does not form channels itself but regulates them (Liu2019Calciumactivated).

Structurally, CLCA1 contains several distinct domains, including a von Willebrand factor type A (VWA) domain, a fibronectin type III (FnIII) domain, and a zinc-dependent metalloprotease catalytic domain within its N-terminus (Yurtsever2012Selfcleavage; Nyström2019Calciumactivated). The VWA domain is crucial for protein-protein interactions and may influence chloride channel activity (Liu2019Calciumactivated). The protein undergoes post-translational modifications, such as glycosylation, which are important for its folding, secretion, and solubility (Nyström2019Calciumactivated).

CLCA1 forms non-covalent oligomers and disulfide-linked dimers, contributing to its quaternary structure (Nyström2019Calciumactivated). The protein is cleaved into N- and C-terminal fragments, with the N-terminal fragment being essential for activating calcium-activated chloride channels (Yurtsever2012Selfcleavage). The cleavage is autocatalytic and occurs early in the secretory pathway (Nyström2019Calciumactivated).

## Function
The CLCA1 gene encodes a protein that plays a crucial role in modulating calcium-dependent chloride currents in human cells. This protein is part of the calcium-activated chloride channel regulator (CLCA) family and is primarily involved in the regulation of chloride ion transport across epithelial cell membranes. CLCA1 functions by interacting with the TMEM16A/Anoctamin1 channel, a calcium-activated chloride channel, to enhance its activity. This interaction stabilizes TMEM16A on the cell surface, preventing its internalization and increasing chloride ion flow, which is essential for various physiological processes (SalaRabanal2015Secreted).

In healthy human cells, CLCA1 is predominantly expressed in the small intestine, colon, and appendix, where it contributes to mucus dynamics and homeostasis. It is involved in epithelial fluid secretion, mucus production, and cell signaling, playing a significant role in maintaining the integrity and function of the gastrointestinal tract (Liu2019Calciumactivated). The protein's activity is crucial for maintaining normal respiratory function and preventing excessive mucus production, which can lead to respiratory diseases (SalaRabanal2015Secreted).

## Clinical Significance
The CLCA1 gene is clinically significant in several diseases due to its role in regulating chloride ion transport and mucus production. In colorectal cancer (CRC), CLCA1 acts as a tumor suppressor. Its expression is significantly decreased in CRC tissues compared to normal tissues, and lower serum levels are observed in patients. This downregulation is associated with increased tumor aggressiveness, metastasis, and poorer survival rates. CLCA1 suppresses CRC progression by inhibiting the Wnt/beta-catenin signaling pathway and epithelial-mesenchymal transition (EMT) (Liu2019Calciumactivated; Li2017CLCA1).

In respiratory diseases, CLCA1 is implicated in asthma and chronic obstructive pulmonary disease (COPD). In asthma, overexpression of CLCA1 is linked to mucin overproduction and airway hyperresponsiveness, contributing to disease pathogenesis. Genetic polymorphisms in CLCA1 have been associated with increased susceptibility to asthma and COPD, affecting mucus production and inflammation (Liu2019Calciumactivated; Hegab2004CLCA1). In COPD, CLCA1 overexpression may lead to excessive mucus production, exacerbating conditions like chronic bronchitis (Hegab2004CLCA1). These findings highlight the gene's potential as a biomarker and therapeutic target in these diseases.

## Interactions
CLCA1, a secreted protein, interacts with the TMEM16A protein to modulate calcium-dependent chloride currents in human cells. This interaction occurs on the cell surface, where CLCA1 stabilizes TMEM16A, enhancing its surface expression and preventing its internalization. This stabilization increases the activity of TMEM16A, a calcium-dependent chloride channel, thereby facilitating chloride ion flow (SalaRabanal2015Secreted).

The interaction between CLCA1 and TMEM16A is mediated by the N-terminal fragment of CLCA1. This fragment directly associates with TMEM16A, as demonstrated by experiments using a biotinylated N-terminal fragment of CLCA1 that binds to TMEM16A. The binding is specific, as it is significantly reduced by an anti-TMEM16A antibody (SalaRabanal2015Secreted).

CLCA1 also participates in the proteolytic processing of MUC2, a mucin protein in colonic mucus. It acts as a metalloprotease, cleaving the N-terminal part of MUC2 in a calcium-dependent manner. This activity suggests a role for CLCA1 in mucus structure rearrangements, potentially affecting mucus detachment and processing (Nyström2019Calciumactivated).


## References


[1. (Liu2019Calciumactivated) Cong-Lin Liu and Guo-Ping Shi. Calcium-activated chloride channel regulator 1 (clca1): more than a regulator of chloride transport and mucus production. World Allergy Organization Journal, 12(11):100077, November 2019. URL: http://dx.doi.org/10.1016/j.waojou.2019.100077, doi:10.1016/j.waojou.2019.100077. This article has 37 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.waojou.2019.100077)

[2. (Li2017CLCA1) Xiaofen Li, Wangxiong Hu, Jiaojiao Zhou, Yanqin Huang, Jiaping Peng, Ying Yuan, Jiekai Yu, and Shu Zheng. Clca1 suppresses colorectal cancer aggressiveness via inhibition of the wnt/beta-catenin signaling pathway. Cell Communication and Signaling, October 2017. URL: http://dx.doi.org/10.1186/s12964-017-0192-z, doi:10.1186/s12964-017-0192-z. This article has 51 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12964-017-0192-z)

[3. (Nyström2019Calciumactivated) Elisabeth E.L. Nyström, Liisa Arike, Erik Ehrencrona, Gunnar C. Hansson, and Malin E.V. Johansson. Calcium-activated chloride channel regulator 1 (clca1) forms non-covalent oligomers in colonic mucus and has mucin 2–processing properties. Journal of Biological Chemistry, 294(45):17075–17089, November 2019. URL: http://dx.doi.org/10.1074/jbc.ra119.009940, doi:10.1074/jbc.ra119.009940. This article has 34 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra119.009940)

[4. (SalaRabanal2015Secreted) Monica Sala-Rabanal, Zeynep Yurtsever, Colin G Nichols, and Tom J Brett. Secreted clca1 modulates tmem16a to activate ca2+-dependent chloride currents in human cells. eLife, March 2015. URL: http://dx.doi.org/10.7554/elife.05875, doi:10.7554/elife.05875. This article has 78 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.05875)

[5. (Yurtsever2012Selfcleavage) Zeynep Yurtsever, Monica Sala-Rabanal, David T. Randolph, Suzanne M. Scheaffer, William T. Roswit, Yael G. Alevy, Anand C. Patel, Richard F. Heier, Arthur G. Romero, Colin G. Nichols, Michael J. Holtzman, and Tom J. Brett. Self-cleavage of human clca1 protein by a novel internal metalloprotease domain controls calcium-activated chloride channel activation. Journal of Biological Chemistry, 287(50):42138–42149, December 2012. URL: http://dx.doi.org/10.1074/jbc.m112.410282, doi:10.1074/jbc.m112.410282. This article has 60 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m112.410282)

[6. (Hegab2004CLCA1) A E Hegab. Clca1 gene polymorphisms in chronic obstructive pulmonary disease. Journal of Medical Genetics, 41(3):27e–227, March 2004. URL: http://dx.doi.org/10.1136/jmg.2003.012484, doi:10.1136/jmg.2003.012484. This article has 27 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1136/jmg.2003.012484)